National Cancer Research Institute (Ncri)

National Cancer Research Institute (Ncri) company information, Employees & Contact Information

The National Cancer Research Institute (NCRI) is a UK-wide partnership between cancer research funders, which promotes collaboration in the field. Our role is to promote co-operation in cancer research for the benefit of patients, the public and the scientific community. We focus on challenging areas of research where partners can achieve greater progress by working together. What we do: • We run the annual NCRI Cancer Conference, which is the leading meeting in the UK for showcasing cancer research. It covers a spectrum of basic, clinical, translational and patient-focused research, and attracts around 2000 delegates. • We identify areas of need in UK cancer research and set up collaborative initiatives to help address them. • We collect information every year on how much is being spent on cancer research in the UK by NCRI partners, to inform funding strategies and identify areas of need and opportunity. What we don’t do: • We don’t fund research – each of our partners does this directly through a variety of funding streams. • We don’t lobby – we work mainly by promoting coordination, collaboration and communication.

Company Details

Employees
86
Founded
-
Address
2 Redman Place, London,london E20 1jq,united Kingdom
Phone
+44 (0)20 3469 8460
Email
in****@****.org.uk
Industry
Research Services
NAICS
Scientific Research and Development Services
Research and Development in the Physical, Engineering, and Life Sciences
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
London, London
Looking for a particular National Cancer Research Institute (Ncri) employee's phone or email?

National Cancer Research Institute (Ncri) Questions

News

UK Parliament Marks Third Anniversary of Iran’s 2022 Uprising, Lawmakers Back NCRI Alternative - National Council of Resistance of Iran - NCRI

UK Parliament Marks Third Anniversary of Iran’s 2022 Uprising, Lawmakers Back NCRI Alternative National Council of Resistance of Iran - NCRI

Professor Johann de Bono to chair NCRI Cancer Conference - The Institute of Cancer Research

Professor Johann de Bono to chair NCRI Cancer Conference The Institute of Cancer Research

A blow to cancer research in the UK as National Cancer Institute closes down - Clinical Trials Arena

A blow to cancer research in the UK as National Cancer Institute closes down Clinical Trials Arena

UK Parliament: 560 Lawmakers Urge Robust Action on Iran, Back NCRI - National Council of Resistance of Iran - NCRI

UK Parliament: 560 Lawmakers Urge Robust Action on Iran, Back NCRI National Council of Resistance of Iran - NCRI

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial | Journal of Clinical Oncology - ASCO Publications

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial | Journal of Clinical Oncology ASCO Publications

‘Help us to celebrate the role of the modern cancer clinical nurse specialist’ - Nursing Times

‘Help us to celebrate the role of the modern cancer clinical nurse specialist’ Nursing Times

Iran News: UK Parliament Debates National Security Measures Targeting Regime’s Influence - National Council of Resistance of Iran - NCRI

Iran News: UK Parliament Debates National Security Measures Targeting Regime’s Influence National Council of Resistance of Iran - NCRI

Could a blood test for breast cancer be on the horizon? - BioTechniques

Could a blood test for breast cancer be on the horizon? BioTechniques

CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom - Nature

CM-Path Molecular Diagnostics Forum—consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom Nature

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma | Journal of Clinical Oncology - ASCO Publications

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography–Directed Therapy for Early-Stage Hodgkin Lymphoma | Journal of Clinical Oncology ASCO Publications

UK Parliament’s Nowruz Gathering Calls for Accountability Against Iran’s Clerical Regime - National Council of Resistance of Iran - NCRI

UK Parliament’s Nowruz Gathering Calls for Accountability Against Iran’s Clerical Regime National Council of Resistance of Iran - NCRI

NCRI 2021: Cancer researchers reconvene virtually for UK’s largest cancer conference - The Institute of Cancer Research

NCRI 2021: Cancer researchers reconvene virtually for UK’s largest cancer conference The Institute of Cancer Research

UK Parliamentarians Champion ‘Third Option’ for Iran, Rejecting War and Appeasement - National Council of Resistance of Iran - NCRI

UK Parliamentarians Champion ‘Third Option’ for Iran, Rejecting War and Appeasement National Council of Resistance of Iran - NCRI

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations | J - ASCO Publications

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations | J ASCO Publications

Cross-Party Meeting in UK Parliament Addresses Iranian Regime’s Actions - National Council of Resistance of Iran - NCRI

Cross-Party Meeting in UK Parliament Addresses Iranian Regime’s Actions National Council of Resistance of Iran - NCRI

Former Speaker John Bercow: There Is an Alternative—It’s the NCRI and the Iranian People’s Fight for Freedom - National Council of Resistance of Iran - NCRI

Former Speaker John Bercow: There Is an Alternative—It’s the NCRI and the Iranian People’s Fight for Freedom National Council of Resistance of Iran - NCRI

UK Parliament Condemns Iranian Regime’s Crackdown on Dissidents - National Council of Resistance of Iran - NCRI

UK Parliament Condemns Iranian Regime’s Crackdown on Dissidents National Council of Resistance of Iran - NCRI

Prominent Global Leaders Unite in Support of Resistance and Democracy in Iran - National Council of Resistance of Iran - NCRI

Prominent Global Leaders Unite in Support of Resistance and Democracy in Iran National Council of Resistance of Iran - NCRI

UK Parliament Committee Raises Alarm Over Iranian Regime's Repression Targeting Dissidents - National Council of Resistance of Iran - NCRI

UK Parliament Committee Raises Alarm Over Iranian Regime's Repression Targeting Dissidents National Council of Resistance of Iran - NCRI

NCRI 2014 conference summary – day 4 - Cancer Research UK - Cancer News

NCRI 2014 conference summary – day 4 Cancer Research UK - Cancer News

The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors - Nature

The National Cancer Survivorship Initiative: new and emerging evidence on the ongoing needs of cancer survivors Nature

Iranian Youth Conference in the British Parliament Highlights Voices for Change - National Council of Resistance of Iran - NCRI

Iranian Youth Conference in the British Parliament Highlights Voices for Change National Council of Resistance of Iran - NCRI

Iran News: UK Minister Reiterates Commitment to Preventing Nuclear Iran - National Council of Resistance of Iran - NCRI

Iran News: UK Minister Reiterates Commitment to Preventing Nuclear Iran National Council of Resistance of Iran - NCRI

Trial re-investment to build better research for better impact - The Lancet

Trial re-investment to build better research for better impact The Lancet

Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison - ScienceDirect.com

Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison ScienceDirect.com

Debate in UK House of Commons on Iran’s Protests - National Council of Resistance of Iran - NCRI

Debate in UK House of Commons on Iran’s Protests National Council of Resistance of Iran - NCRI

Big data analysis predicts risk of radiotherapy side effects - Medical Xpress

Big data analysis predicts risk of radiotherapy side effects Medical Xpress

Clinical development of new drug–radiotherapy combinations - Nature

Clinical development of new drug–radiotherapy combinations Nature

International Women’s Day Conference in Paris - NCRI Women Committee

International Women’s Day Conference in Paris NCRI Women Committee

Guidelines for the welfare and use of animals in cancer research - Nature

Guidelines for the welfare and use of animals in cancer research Nature

Ebrahim Raisi Should Face Justice for Role in 1988 Massacre – Express.co.uk - National Council of Resistance of Iran - NCRI

Ebrahim Raisi Should Face Justice for Role in 1988 Massacre – Express.co.uk National Council of Resistance of Iran - NCRI

Heat-activated ‘grenade’ to target cancer - Cancer Research UK - Cancer News

Heat-activated ‘grenade’ to target cancer Cancer Research UK - Cancer News

New symptoms identified to help doctors diagnose pancreatic cancer - cancer.ox.ac.uk

New symptoms identified to help doctors diagnose pancreatic cancer cancer.ox.ac.uk

Free Iran World Summit 2023: Onward to a Democratic Iran - NCRI Women Committee

Free Iran World Summit 2023: Onward to a Democratic Iran NCRI Women Committee

NCRI 2017: Dr Gerhardt Attard wins Cancer Research UK Future Leaders Prize - The Institute of Cancer Research

NCRI 2017: Dr Gerhardt Attard wins Cancer Research UK Future Leaders Prize The Institute of Cancer Research

Fleshing out the data: when epidemiological researchers engage with patients and carers. Learning lessons from a patient involvement activity - BMJ Open

Fleshing out the data: when epidemiological researchers engage with patients and carers. Learning lessons from a patient involvement activity BMJ Open

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial - Nature

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial Nature

Iranian women prohibited from singing and playing music under the mullahs’ rule - NCRI Women Committee

Iranian women prohibited from singing and playing music under the mullahs’ rule NCRI Women Committee

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups - STT Info

Clovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk Subgroups STT Info

Top National Cancer Research Institute (Ncri) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant